Harrow: California Accusation, Settlement Could Spur Other State Boards of Pharmacy to Take Action Against ImprimisRx

Harrow (HROW), an ophthalmic drug company, announced last week that its compounding business had reached a settlement with the California Board of Pharmacy, paying a fine of $157,000 and voluntarily surrendering its state licensure in light of an August 2025 accusation from the Board. Plaintiff Anne Sodergren, executive officer of the California Board of Pharmacy, […]

FCC General Counsel Candeub Emerges as Leading Contender for Top DOJ Antitrust Post

Adam Candeub, the Federal Communications Commission’s general counsel, has emerged as a leading candidate to be nominated to lead DOJ’s antitrust division, sources familiar with the matter...

May 08, 2026 Read Now >

Roblox: Additional Child Exploitation Lawsuits Consolidated in State and Federal Court as Attorneys Say Thousands of Similar Cases Being Investigated

Thousands of potential cases of child sexual exploitation allegedly facilitated by gaming platform Roblox (RBLX) are still under investigation, according to plaintiffs’ attorneys, as federal...

May 08, 2026 Read Now >

Paramount Skydance/Warner Bros. Discovery: State AGs Ask Movie Theater Owners About Sitting for Depositions, Testifying in Court

A group of Democratic state attorneys general have taken another step toward challenging Paramount Skydance’s (PSKY) proposed Warner Bros. Discovery (WBD) acquisition by asking movie theater owners...

May 06, 2026 Read Now >

Harrow: California Accusation, Settlement Could Spur Other State Boards of Pharmacy to Take Action Against ImprimisRx

RELATED ARTICLES | Editor’s picks

FCC General Counsel Candeub Emerges as Leading Contender for Top DOJ Antitrust Post

Roblox: Additional Child Exploitation Lawsuits Consolidated in State and Federal Court as Attorneys Say Thousands of Similar Cases Being Investigated

Paramount Skydance/Warner Bros. Discovery: State AGs Ask Movie Theater Owners About Sitting for Depositions, Testifying in Court

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.